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Abstract: Age-related strength and muscle mass loss is further increased after acute periods of
inactivity. To avoid this, resistance training has been proposed as an effective countermeasure, but the
additional effect of a protein supplement is not so clear. The aim of this study was to examine the
effect of a whey protein supplement enriched with leucine after resistance training on muscle mass
and strength gains in a post-hospitalized elderly population. A total of 28 participants were included
and allocated to either protein supplementation or placebo supplementation following resistance
training for 12 weeks (2 days/week). Physical function (lower and upper body strength, aerobic
capacity and the Short Physical Performance Battery (SPPB) test), mini nutritional assessment (MNA)
and body composition (Dual X-ray Absorptiometry) were assessed at baseline and after 12 weeks of
resistance training. Both groups showed improvements in physical function after the intervention
(p < 0.01), but there were no further effects for the protein group (p > 0.05). Muscle mass did not
improve after resistance training in either group (p > 0.05). In conclusion, 12 weeks of resistance
training are enough to improve physical function in a post-hospitalized elderly population with no
further benefits for the protein-supplemented group.
Keywords: elderly; aging; muscle mass; strength; resistance training; leucine; whey protein;
protein supplementation
1. Introduction
Aging is characterized by a progressive decline in skeletal muscle mass and function defined
as sarcopenia [1]. Sarcopenia is related to an increased risk of falling [1], fractures [2], physical
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disability [3] and mortality [4]. In healthy aging, muscle mass loss ranges from 3% to 8% per decade [5].
However, this decline is further emphasized by acute or chronic illness [6], inactivity [6] and inadequate
protein and/or energy intake [7]. So, physical activity is proposed as an effective countermeasure to
delay the age-related muscle mass loss [7]. Indeed, following a healthy lifestyle may help to prevent
and reduce the consequences of age-related muscle mass loss [7].
A balanced protein metabolism is important to muscle mass accretion and maintenance [8].
Energy and protein intake are key nutritional factors to achieve protein balance [7]. However, due to
several physiological and social factors, elderly people tend to reduce food intake and, in consequence,
often fail to meet energy and protein requirements [9]. Likewise, protein-energy malnutrition is
frequent in elderly patients [9]. Besides total daily protein intake [10], dietary protein quality and its
anabolic potential have also received increased interest with the goal of optimizing skeletal muscle
anabolism in the elderly [10,11].
Dietary protein quality depends on its digestibility, amino acid (AA) profile and AA availability [12,13].
Therefore, in studies aiming to optimize muscle mass among elderly people, whey protein (≈20 g/day) is
considered superior to other isolated protein sources [14,15]. Whey protein is also characterized for being a
high leucine-containing protein, which is the main precursor for activating muscle protein synthesis via
mammalian target of rapamycin (mTOR) signaling [8,16]. A protein/AA source containing around 1.8–2.0 g
of leucine would be enough to activate post-exercise “leucine trigger”, whereas in rested conditions,
a higher dose might be required in young adults [16]. Other authors [15], reported that 20 g of whey
protein enriched with 3 g of leucine post-exercise resulted in a greater muscle protein synthesis rate in
healthy older people.
Muscle mass accretion and strength gain depend on the synergistic effect of protein consumption
and resistance training [8,16]. Protein ingestion close after exercise seems to increase exercise-induced
muscle mass sensitivity to anabolism [8]. In a recent systematic review and meta-analysis [17], it was
concluded that a combination of protein supplementation and resistance training led to positive effects
on body composition, muscle volume and strength, and physical function in elderly people. In contrast,
in people aged 70 years or older, it was shown that despite overall improvements from baseline for the
majority of outcomes, there were no significant differences between the group receiving protein/AA
supplementation along with resistance training and the group with resistance training alone [18].
Acute periods of inactivity, such as a hospital stay, accentuates age-related muscle mass loss [6].
After hospitalization, older individuals are more vulnerable to develop any adverse event [19].
Then, early interventions to accelerate recovery and avoid hospital readmission will be important [20].
For example, implementing interventions that combine nutrition and physical exercise immediately
after discharge [20].
In view of this growing interest, the objective of the present study was to examine the effect
of a whey protein supplement enriched with leucine after resistance training on muscle mass and
strength gains in a post-hospitalized elderly population. We hypothesized that elderly people after
hospitalization may benefit most from the synergetic effect of protein supplementation and a resistance
training session.
2. Methods
2.1. Study Design
The Sarcopenia and Fragilidad-protein (S and F-PROT) study is a prospective, 24-week,
single-blind, randomized, placebo-controlled clinical trial (ClinicalTrials.gov ID: NCT03815201).
The study was conducted at the facilities of the Araba University Hospital in Vitoria-Gasteiz (North
Spain), from September 2017 to July 2018. The Clinical Research Ethics Committee of the Araba
University Hospital (CEIC-HUA: 2017-021) approved the study protocol (S and F-PROT) that complied
with the revised ethical guidelines of the Declaration of Helsinki (revision of 2013). All participants
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were informed about the details of the research and signed an informed consent before their enrolment
in the study.
The S and F-PROT project compared relative changes on functional capacity (muscular strength
of upper and lower limbs, and aerobic capacity), body composition (lean mass and fat mass at whole
body, arms, legs and trunk) and nutritional status between two groups following a resistance training
intervention program with post-exercise supplementation (Protein-group) or without supplementation
(Placebo-group).
2.2. Participants
Volunteers accessed the program after hospitalization at the internal medicine service of the Araba
University Hospital, or by medical recommendation at the outpatient internal medicine specialty
at the Araba University Hospital (Figure 1). Hospitalized patients older than 70 years old were
first pre-screened for eligibility. All pre-screened participants met the following criteria: >70 years
old, a punctuation of ≥20 at the Mini Mental State Questionnaire (MMSE), fulfilled the criteria for
sarcopenia diagnosis of the European Working Group on Sarcopenia in Older People, were able to
walk alone or using a walking stick, a walking frame, or parallel walking bars, were able to understand
the instructions or what had being said, and signed the informed consent. Patients were excluded
for examination if they had any of the following exclusion criteria: history of chronic kidney disease,
had suffered a heart attack in the last 3 months, been unable to walk, have suffered any fracture
of the upper or lower limbs in the last 3 months, been suffering from severe dementia, a history of
autoimmune neuromuscular disorders (for example, myasthenia gravis, Guillain–Barré syndrome,
inflammatory myopathies) or amyotrophic lateral sclerosis, or refused to sign the informed consent.
Patients that were eligible for the intervention program were assessed for nutritional status (Mini
Nutritional Assessment-Short Form (MNA-SF; Nestlé Nutrition Institute)) [21], physical function (Short
Physical Performance Battery (SPPB) [22] and handgrip strength), frailty (a Spanish language version
of the Fried test [23]) and cognitive function (Spanish validated version of the Pfeiffer test, the Short
Portable Mental Status Questionnaire (SPMSQ) [24]) during their hospitalization. Patients were
informed about the possibility of participating in an exercise training program after hospital discharge
and an informed consent was given along with further written information. After a recovery week,
patients were cited for baseline physical function assessment before initiating the intervention program.
Many hospitalized patients did not meet inclusion criteria when assessing eligibility (21.8%)
or refused to participate (66.6%) because of health issues, lack of interest in the physical exercise
program, or had problems to get to hospital for the intervention sessions. As the hospital recruitment
proved not to be enough for the intervention aims, the outpatient internal medicine service was
chosen as an alternative recruitment source. Those patients at the outpatient internal medicine service
potentially meeting inclusion criteria were informed by their doctor about the exercise intervention
program. Thereafter, patients were cited for a first eligibility assessment with the investigation team.
If participation criteria were met, patients were again cited a week after for baseline physical function
assessment (Figure 1).
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2.3. Randomization
Following baseline physical function assessment, participants were randomly allocated to one of
the two intervention groups: Placebo-group or Protein-group. Participant stratification was based on
gender to ensure equal allocation in both groups.
2.4. Supplementation and Blinding
Placebo and protein supplements were delivered by the nutritionist in the first half hour following
each training session. The protein supplement contained 20 g of whey protein isolate (Davisco ®:
BiPRO all-natural whey protein isolate, Eden Paririe, MN, USA) enriched with 3 g of leucine (Nutricia,
Madrid, Spain). The nutritional composition of both the placebo and protein supplement is shown in
Table 1. The supplements were energy-matched and were flavored with lemon flavor and solubilized
in 150 mL of water. Only participants were blinded for supplementation. Supplements were stored in
boxes and only th research team ould id ntify them. All supplements were d veloped, prepared and
stored in boxes by L bo ator um Sanitatis SL (Tecnalia Research and In ovation, Vitoria-Gasteiz, Spain).
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Table 1. Nutritional composition of the protein and placebo supplements.
Nutritional Composition Protein Supplement
B-lactoglobulin (g/bottle) 20
L-Leucine (g/bottle) 3
Sodium saccharin (g/bottle) 0.050
Sucralose (g/bottle) 0.030
Lemon flavor 654500 (g/bottle) 0.250
Placebo supplement
Maltodextrin (g/bottle) 23
Hydroxyethylcellulose (g/bottle) 0.200
Lemon flavor 654500 (g/bottle) 0.250
2.5. Design of the Resistance Training Program
Both groups followed a supervised resistance training program for 12 weeks. The program consisted
of 1 h sessions on two non-consecutive days per week. The first week of intervention was used for
familiarization, and 1-RM (repetition maximum) estimation by the individual’s functional capacity through
Brzycki equation [25]. The load was then gradually increased during a month, and half exercises were
performed at 50%–65% of the estimated 1-RM. During the subsequent months, load was increased until
70% of the estimated 1-RM was reached. Two sets were performed per exercise and load and maximum
repetition for each exercise was personalized for each participant. All resistance training sessions were
designed and supervised by a sport scientist with experience in resistance training for the elderly.
All training sessions started with warm-up exercises (heel stand, calf raises, chair stand exercise
and neck movements) and were followed by strengthening exercises of upper and lower limbs (arm-curl
exercise with the participant in a seated position and personalized load, knee extension exercise with
personalized load in a seated position, standing knee flexion with personalized load, side hip raise,
standing hip extension and chair stand exercise). In the same resistance training session, some exercises
for dynamic balance improvement were also practiced (side-by-side stand, semi-tandem stand, tandem
stand, monopodal stand, timed up and go, stepping around obstacles and step up and down exercises).
The session finished with 5 min of cool-down, consisting mainly of stretching exercises.
2.6. Outcome Measures
Primary and secondary outcomes were assessed at baseline and after 12 weeks of intervention
by the same trained researchers. Post-intervention measurements were scheduled within one week
following the last exercise session.
2.7. Primary Outcome: Physical Function
Physical function was assessed at baseline and at week 13 (once supervised intervention period
was finished).
Physical function was assessed using a combination of tests. The tests used to assess lower and
upper body strength and aerobic capacity were based on the Senior Fitness Test [26]. For lower and
upper body strength, 30-Second Chair Stand Test and 30-Second Arm Curl Test were used, respectively.
For upper body strength, isometric handgrip strength was also measured using a handled dynamometer
(JAMAR® PLUS + Hand dynamometer). Aerobic capacity was assessed by the 6 min walking test
(6MWT). Hence, for physical function assessment, the SPPB test battery was also used [22]. This test
includes the 4 m walking speed test, the standing balance test (side-by-side stand, semi-tandem stand
and tandem stand) and the time to rise from a chair five times test [22].
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2.8. Secondary Outcomes
2.8.1. Nutritional Assessment
A nutritionist completed all nutritional questionnaires along with the participant and/or
participant’s relative or caregiver. Participant’s nutritional status was assessed using the MNA
questionnaire (Nestlé Nutritional Institute) [27]. This questionnaire contains 18 items divided into
4 categories: anthropometric assessment, general assessment, short dietary assessment and subjective
assessment [27]. Each answer has a numerical value contributing to the final punctuation. A maximum
of 30 points can be obtained. Punctuation ranging from 24 to 30 reflects normal nutritional status, from
17 to 23.5 risk of malnutrition and a punctuation under 17 reflects malnutrition [27].
2.8.2. Body Composition
Body fat, lean mass, bone mass, bone mineral density (BMD) and bone mineral content (BMC)
were assessed by dual-energy X-ray absorptiometry (DXA; HOLOGIC, QDR 4500).
Body mass (OMRON HN-288, Digital Personal Scale, Barcelona, Spain) was measured barefoot
following the standard protocols. Height was estimated using knee height determination (SECA
220, Hamburg, Germany) [28]. Body mass index (BMI) was calculated as body weight divided by
height squared (kg/m2). Waist circumference, hip circumference, calf circumference and mid-arm
circumference were measured with a nonelastic tape (CESCORF, Porto Alegre, Brasil) following the
protocol recommended by the International Society for the Advancement of Kinanthropometry (ISAK).
2.8.3. Biochemical Parameters
Biochemical parameters were obtained from fasting venous blood samples in
Ethylenediaminetetraacetic acid -containing tubes and in serum tubes. These tubes were immediately
carried to the laboratory and EDTA-containing tubes were centrifuged at 1000× g at 4 ◦C for 10 min,
whereas serum tubes were centrifuged 90 min after blood collection at 1000× g at 20 ◦C for 15 min.
Serum albumin, prealbumin and creatinine were measured as protein malnutrition markers.
2.9. Statistical Analysis
Baseline characteristics between groups (i.e., placebo versus protein supplementation) were
compared using independent Student’s t-test.
Sample size estimation and power analysis was calculated for muscle mass increase. With a
population size of 35 on each group, a significant alpha level of 0.05, and power >80%, the range for a
statistically detectable change in muscle mass will be 1.5–2kg with a standard deviation of 1.5–1.7 kg.
Data analysis was performed following the per-protocol principle. Changes in primary
and secondary outcomes were calculated as Post-intervention minus Pre-intervention values.
Differences between the placebo and the protein groups (fixed factor) in changes on primary outcomes
and secondary outcomes were calculated by analyses of covariance adjusting with baseline values.
All statistical analyses were performed using the statistical software SPSS version 20.0 (SPSS Inc.,
Chicago, IL, USA) with a level of significance of α = 0.05. Data are expressed as means ± standard
error of the mean.
3. Results
During the recruitment period, a total of 476 hospitalized patients were evaluated and invited to
participate in the study. From them, only 74 (15.5%) accepted to participate, whereas the remaining
402 patients refused to participate (83.4%) or did not meet inclusion criteria (1.15%). Finally, from the
74 patients who accepted to participate, a total of 29 participants (39.2%) were randomized for the study.
Overall, 93.9% of the evaluated hospitalized patients did not participate in the study due to inclusion
criteria or rejection to participate in the program. Regarding the recruitment from the outpatient internal
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medicine service, a total of 22 patients were recommended to participate, 40.9% of these patients refused
to enter the intervention program or did not meet inclusion criteria (4.5%), whereas 54.54% accepted.
In total, 41 patients were randomized for the intervention program, 20 entered the Placebo-group and
21 the Protein-group. From the allocated participants, 13 did not complete the 12 weeks of the intervention
program (7 from the Placebo-group and 6 from the Protein-group). The main reason for dropping out from
the study in both groups was that participants refused to continue in the program (15.0% of the randomized
patients in the Placebo-group and 14.3% in the Protein-group). In the Protein-group, an adverse event was
reported with protein supplementation regarding itchy throat and difficulties to inhale, whereas another
participant refused to take the protein supplement, so both participants were dropped from the study
(Figure 1). Baseline characteristics of the recruited participants can be found in Supplemental Table S1.
Table 2 shows baseline characteristics of participants. There were no statistically significant
differences in body composition and nutritional status variables between groups at baseline.
However, within the physical function parameters, the protein-group walked significantly more
meters in the 6MWT at baseline (p < 0.05). In contrast, the Protein-group showed significantly greater
lean mass on the legs (%) than the Placebo-group (p < 0.05).
Table 2. Characteristics of participants completing the study (intend-to-treat analyses).
N Placebo Group N Protein Group p
Age (years) 13 81.7 (6.45) 15 82.9 (5.59) 0.607
Women (N, %) 13 7 (53.8) 15 7 (46.7) 0.717
Body mass (kg) 13 75.9 (17.95) 15 68.0 (11.43) 0.188
BMI (Kg/m2) 13 30.8 (6.53) 15 27.4 (3.50) 0.110
Physical Function
Handgrip (kg/body mass) 13 0.3 (0.09) 15 0.4 (0.09) 0.063
SFT chair stand test 30sec 13 10.6 (4.17) 15 12.3 (2.97) 0.229
SFT arm curl test 30sec 13 13.5 (5.22) 15 16.3 (3.92) 0.137
SFT 6MWT (m) 13 314.8 (139.36) 15 411.5 (80.40) 0.040
SPPB total punctuation 13 8.7 (2.36) 15 10.1 (1.58) 0.089
SPPB 5Squat 13 14.7 (6.85) 15 12.2 (2.86) 0.232
Body composition
Waist to hip ratio 13 1.00 (0.07) 15 0.98 (0.09) 0.459
Lean mass arms (kg) 13 2.3 (0.67) 15 2.3 (0.44) 0.897
Lean mass legs (kg) 13 6.8 (1.70) 15 6.4 (1.08) 0.441
Lean mass trunk (kg) 13 23.0 (4.83) 15 21.5 (3.89) 0.380
Total lean mass (kg) 13 45.2 (9.85) 15 42.3 (6.63) 0.391
Fat mass arms (%) 13 2.6 (0.96) 15 2.4 (0.77) 0.545
Fat mass legs (%) 13 5.8 (1.85) 15 5.4 (1.84) 0.603
Fat mass trunk (%) 13 17.1 (3.87) 15 14.9 (3.03) 0.124
Total fat mass (%) 13 35.4 (8.05) 15 32.1 (6.84) 0.259
Nutritional Status
MNA score 13 23.1 (3.82) 15 24.5 (2.11) 0.273
Normal nutritional status (N, %) 13 4 (30.8) 15 11 (73.3) 0.064
At risk of malnutrition (N, %) 13 8 (61.5) 15 4 (26.7)
Malnourished (N, %) 13 1 (7.7) 15 0 (0)
Biomarkers
Creatinine (mg/dL) 10 1.1 (0.48) 15 0.9 (0.35) 0.401
Albumin (g/dL) 13 4.0 (0.39) 15 4.0 (0.31) 0.994
Prealbumin (mg/dL) 12 22.2 (6.63) 14 23.3 (4.31) 0.613
BMI: body mass index; MNA score: Mini Nutritional Assessment score; SFT chair stand test 30 s: Senior Fitness Test
chair stand test 30 s; SFT arm curl test 30 s: Senior Fitness Test arm curl test 30 s; SFT 6MWT (m): Senior Fitness
Test 6-min Walking Test (m); SPPB total punctuation: Short Physical Performance Battery total punctuation; SPPB
5Squat: Short Physical Performance Battery 5Squat. Values are means and standard deviations.
3.1. Effects of the Intervention on Primary Outcomes: Physical Function
Both groups showed improvements over time in all the physical function tests (p < 0.01), except for
the handgrip strength test (Table 3). However, we did not observe any significant difference between
groups in any of the measured physical function tests (Table 3).
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Table 3. Body composition, nutritional status and physical function in elderly patients before (Pre) and after (Post) their participation in the resistance exercise
intervention program plus protein supplementation (Protein-group) or placebo (placebo-group) (analyses per protocol).
Placebo-Group Protein-Group Differences between Groups
N Pre Post p N Pre Post p ∆ Placebo ∆ Protein p
Primary outcome
Physical function
Handgrip (kg/body mass) 13 0.3 (0.09) 0.3 (0.09) 0.775 15 0.4 (0.09) 0.4 (0.09) 0.651 0.0 (0.03) -0.0 (0.06) 0.971
SFT chair stand test 30sec 13 10.6 (4.17) 13.5 (4.59) 0.003 15 12.3 (2.97) 14.4 (3.22) <0.001 2.8 (2.79) 2.1 (1.53) 0.480
SFT arm curl test 30sec 13 13.5 (5.22) 21.9 (4.66) <0.001 15 16.3 (3.92) 23.5 (4.53) <0.001 8.4 (5.74) 7.2 (4.86) 0.724
SFT 6min WT (m) 13 314.8 (139.36) 375.0 (128.39) 0.002 15 411.5 (80.4) 455.1 (81.77) 0.005 60.2 (53.67) 43.6 (51.2) 0.959
SPPB total score 13 8.7 (2.36) 10.3 (1.89) 0.001 15 10.1 (1.58) 11.3 (0.96) 0.002 1.6 (1.39) 1.2 (1.21) 0.634
SPPB 5Squat 13 14.7 (6.85) 10.6 (3.67) 0.005 15 12.2 (2.86) 10.0 (2.81) 0.004 −4.1 (4.32) –2.2 (2.4) 0.491
Secondary outcomes
Body composition
Body mass (kg) 13 75.9 (17.95) 75.6 (18.31) 0.621 15 68.0 (11.43) 68.3 11.07) 0.500 −0.3 (2.24) 0.3 (1.60) 0.471
BMI (kg/m2) 13 30.8 (6.54) 30.7 (6.64) 0.575 15 27.4 (3.5) 27.5 (3.37) 0.453 −0.3 (2.24) 0.3 (1.60) 0.493
Waist to hip ratio 13 1.00 (0.07) 1.00 (0.08) 0.818 15 0.98 (0.09) 0.96 (0.08) 0.255 −0.0 (0.06) −0.0 (0.05) 0.400
Lean mass arms (kg) 13 2.3 (0.67) 2.3 (0.41) 0.937 15 2.3 (0.44) 2.2 (0.41) 0.049 0.0 (0.36) −0.1 (0.24) 0.088
Lean mass legs (kg) 13 6.8 (1.7) 6.9 (1.45) 0.630 15 6.4 (1.08) 6.5 (1.04) 0.260 0.1 (0.64) 0.1 (0.34) 0.756
Lean mass trunk (kg) 13 23.0 (4.83) 22.6 (4.47) 0.212 15 21.5 (3.88) 21.7 (3.61) 0.198 −0.4 (1.21) 0.2 (0.67) 0.128
Total lean mass (kg) 13 45.2 (9.85) 44.7 (8.54) 0.545 15 42.3 (6.63) 42.5 (6.61) 0.458 −0.4 (2.52) 0.2 (1.02) 0.611
Fat mass arms (%) 13 2.6 (0.96) 2.6 (0.85) 0.808 15 2.4 (0.77) 2.3 (0.92) 0.291 −0.0 (0.56) −0.1 (0.41) 0.575
Fat mass legs (%) 13 5.8 (1.85) 5.9 (2.07) 0.165 15 5.4 (1.84) 5.5 (1.69) 0.506 0.2 (0.45) 0.1 (0.46) 0.549
Fat mass trunk (%) 13 17.1 (3.86) 16.7 (3.31) 0.448 15 14.9 (3.03) 15.7 (2.61) 0.061 −0.4 (1.86) 0.7 (1.31) 0.297
Total fat mass (%) 13 35.4 (8.05) 35.2 (7.53) 0.728 15 32.1 (6.84) 32.7 (6.64) 0.092 −0.2 (1.91) 0.6 (1.31) 0.357
Nutritional status
MNA score 13 23.1 (3.8) 25.3 (2.2) 0.010 15 24.5 (2.1) 26.2 (1.6) 0.019 2.2 (2.6) 1.7 (2.5) 0.512
Normal nutritional status (N. %) 13 4(30.8) 9(69.3) 0.123 15 11(73.3) 14(93.4) 0.533
At risk of malnutrition (N. %) 13 8(61.6) 4(30.8) 15 4(26.7) 1(6.7)
Malnourished (N. %) 13 1(7.7) 0 15 0 0
Biomarkers
Creatinine (mg/dL) 10 1.1 (0.48) 1.1 (0.37) 0.664 15 0.9 (0.35) 0.9 (0.32) 0.595 0.0 (0.21) 0.0 (0.14) 0.438
Albumin (g/dL) 13 3.9 (0.39) 4.1 (0.31) 0.189 15 3.9 (0.31) 4.0 (0.26) 0.499 0.1 (0.22) 0.0 (0.15) 0.331
Prealbumin (mg/dL) 12 22.2 (6.63) 20.5 (4.48) 0.221 14 23.3 (4.31) 21.3 (4.17) 0.019 −1.6 (4.36) −1.9 (2.77) 0.916
SFT chair stand test 30sec: Senior Fitness Test chair stand test 30 sec; SFT arm curl test 30 sec: Senior Fitness Test arm curl test 30sec; SFT 6MWT (m): Senior Fitness Test 6-min Walking Test
(m); SPPB total punctuation: Short Physical Performance Battery total punctuation; SPPB 5Squat: Short Physical Performance Battery 5Squat; BMI: body mass index; MNA score: Mini
Nutritional Assessment score. Values are means and standard deviations. *P indicates statistical differences between Pre and Post values (paired Student’s t-test). ∆ placebo indicates the
difference between Pre and Post values in the Placebo-group; ∆ Protein indicates the difference between Pre and Post values in the Protein-group. P indicates statistical significance
between ∆ placebo and ∆ Protein (ANOVA).
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3.2. Effects of the Intervention on Secondary Outcomes
We did not observe any significant difference on body composition measurements within groups
at the end of the intervention, except for lean mass on arms within the protein-group (p < 0.05, Table 3).
There were no significant differences in any of the body composition variables between the two groups
(Table 3).
The MNA scoring improved significantly within both groups after the intervention program (p
< 0.05, Table 3). However, we did not observe any significant difference on changes in MNA score
between groups (p < 0.5, Table 3).
Among serum markers of protein malnutrition, creatinine and albumin concentrations did not
significantly change over time in either group (Table 3). Prealbumin concentrations significantly
decreased in the Protein-group (p < 0.05, Table 3). Nevertheless, there were no significant differences
on changes in protein nutritional status serum biomarkers between groups (Table 3).
4. Discussion
The current study aimed to examine the additional effect of a leucine-enriched protein
supplementation on physical function, skeletal muscle mass and nutritional status after resistance
training in a post-hospitalized elderly population. Results do not show further beneficial effects with
protein and leucine-enriched supplementation after 12 weeks of resistance training (2 sessions/week)
for any of the measured variables. These findings suggest that protein supplementation might not
be determinant to see improvements in muscle mass and strength, and/or the time period of the
intervention was not enough to see significant results.
It is well-established that resistance training is an effective countermeasure to combat age-related
skeletal muscle mass and strength loss [6,29]. It is proposed as a primary intervention for sarcopenia [30],
frailty [31], malnutrition [32] and other geriatric syndromes [7]. Our results are in line with these
guidelines, according to physical function measurements as both groups show improvement after
resistance training.
Resistance training stimulates muscle protein synthesis [33]. To take advantage of this anabolic
stimuli, we considered protein supplementation as a complementary strategy following resistance
training. In line with studies supporting this strategy [15,34], the protein-group received 20 g of
whey protein enriched with 3 g of leucine after each session twice per week. However, there were
no further benefits on physical function for the protein-group in this study. This is in contrast with
some [34–36], but not all [37,38] previous studies. A recent systematic review [18], concluded that
protein/AA supplementation did not further improve muscle strength in older subjects following a
resistance training program. Nevertheless, both groups showed significant improvements in physical
function parameters, except for handgrip strength. This result was also seen in the study carried out
by Leenders et al. [29], where they suggested that handgrip strength is not a clinically relevant and/or
valid measure to evaluate changes in muscle function in response to a resistance training program in
the elderly.
We observed no changes in body composition after the intervention in either group. Again, we did
not see further benefits with protein supplementation. One previous study with participants aged
82 years reported a limited muscle plasticity that further limited strength gains in response to a
progressive resistance training program [39]. So, our results in a population with the same average
age (82 years) underscore the limited capacity to hypertrophy as we age [40]. Furthermore, when
looking for studies regarding muscle mass and strength gains along with protein supplementation,
among many of them, the target adult population are younger than age 80 [34,36,41–43]. The same
issue can be seen in recent systematic reviews and meta-analyses, where most of the included studies
are based in younger populations [44,45]. However, this blunted anabolic response might be overcome,
or at least minimized, if adequate interventions are designed [46]. It seems that the protein synthesis
capacity of the muscle is preserved up to very old age in response to anabolic stimuli [33].
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There is still much controversy regarding protein supplementation in the elderly population
due to poor compliance, high heterogeneity and underpowered studies evident from meta-analysis
and systematic reviews [17,18,45]. Studies underlying protein supplementation as an effective
measure to increase resistance training induced adaptations were based on short-term metabolic
studies [15,34,47]. Conversely, dietary intervention studies, where long-term protein supplementation
have been examined, have failed to observe measurable gains in skeletal muscle mass in the elderly
population [35,37,38]. Tieland et al. supplemented the protein-group with 15 g of protein at breakfast
and lunch for 24 weeks and they reported that protein intake in this group increased to more than
25 g with each meal (daily protein intake increased from 1.0 ± 0.1 to 1.4 ± 0.1g/kg body mass/day) [35].
However, they did not observe measurable gains in skeletal muscle mass for the protein-group as
baseline protein intake was already high [35].
Contrary to Tieland et al. [35], participants in our study entered the interventional program after
hospitalization where they had suffered an acute phase of illness and inactivity, and it would be
reasonable to think that the protein-group should have benefit more from the resistance training along
with protein supplementation. However, during the post-hospitalization period exists an acquired,
transient period of vulnerability known as post-hospital syndrome, where the nutritional requirements
are higher than normal to reverse this acute situation [19,48]. It has been suggested to increase dietary
protein to 1.2–1.5 g/kg body mass/day during acute illness or up to 2.0 g/kg body mass/day in severe
situations [48]. Thus, it could be speculated that if the protein supplementation protocol used in the
study of Tieland et al. was not enough to see gains in muscle mass [35], and neither was the one
applied in our study. It is probably that participants in our study were below the dietary protein
recommendation set for acute phases or that the dietary treatment on this study did not increase the
daily protein intake to have an effect. However, in contrast to Tieland et al. [35], the protein-group in
our study was supplemented immediately after resistance training in order to overcome any daily
protein deficiency and take advantage of the increased exercise-induced anabolic stimuli. In a recent
study conducted in mobility-limited older adults, the protein-group was supplemented after resistance
training with 20 g of whey protein three times per week for six months [42]. Englund et al. concluded
that protein supplementation improved body composition [42]. However, the target population in
the study conducted by Englund et al. had a total SPPB score of ≤9 [42], whereas the protein group
in our study had a baseline total SPPB score of ≥9. This suggests that our participants were in better
physical condition and that they had better body composition, although they entered the program
after an acute illness phase. So, there might be different hypotheses to assess why further benefits were
not seen with protein supplementation in muscle mass accretion. The acute illness phase might have
been the limiting factor which had increased the nutritional requirements of our participants, not only
for protein needs but also daily energy intake. So, it could be that until all nutritional requirements are
met, just twice per week protein supplementation after resistance training is not enough for muscle
mass accretion. Conversely, as baseline protein intake was not reported, it could be that it was already
within the protein dietary recommendation and that our participants in the protein-group were, after
all, within an acceptable range of physical and health condition or that the deviation for protein intake
from baseline was not sufficient to induce muscle mass gains [49].
The latter hypothesis might be more probable because muscle mass did not increase with protein
supplementation, but even more importantly, it did not decrease after resistance training in either
group. This suggests that participants in this study were within the RDA for protein, otherwise
negative protein balance would have occurred hampering muscle mass maintenance [50], and it also
reinforces the idea that healthy elderly people with an adequate daily protein intake might not benefit
from increased protein content [51]. Furthermore, at baseline, participants in the protein-group had
an average punctuation of 24.5 in the MNA, which is considered a normal nutritional status. In turn,
within the placebo-group, the average punctuation was 23.1, so they were almost at risk of malnutrition
according to the MNA. But, following the resistance training program, the mean punctuation in
the placebo-group increased to 25.3, achieving a good nutritional status. These results suggest that
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nutritional requirements were within an acceptable range among both groups leading to improved
physical function variables and maintenance of muscle mass in both groups. Nevertheless, it is
worth to mention that protein supplementation was not prescribed to participant body weight, which
could benefit more muscle mass accretion. It is also important to highlight that the rate of protein
turnover in older adults is slower, so improvements in strength and physical performance are often
seen before measurable changes in skeletal muscle mass become apparent [48]. Thus, it is unlikely
to observe significant changes in muscle mass after only 12 weeks of twice per week supervised
intervention. For muscle mass accretion, a positive protein balance must be achieved over time along
with resistance exercise [50]. Indeed, it might be that the overall volume employed in our resistance
training program was not enough to see gains in muscle mass [52]. In addition, the sample size in this
study might not be enough to see beneficial effects in muscle mass accretion following post-training
protein supplementation [18,49,52].
Limitations and Strength
The current study has several limitations. Daily protein and energy intake of participants
were not controlled, we can merely speculate that probably total daily protein intake, the protein
distribution among meals, the protein supplementation and/or the duration of our interventional
program were not enough to increase muscle mass in this study. In addition, we assessed changes
in body composition by DXA and with this methodology, differences smaller than 1.0 kg are not
detectable [35]. The recruitment was lower than what we expected with only 20 and 21 participants in
the Placebo-group and in the Protein-group, respectively. However, the dropout rate was high with only
13 and 15 participants completing the intervention study in the Placebo-group and in the Protein-group,
respectively. When designing the study, it was proposed that 35 participants should be included to
each group to see detectable improvements in muscle mass. So, this might be the main reason for not
having seen significant improvements in muscle mass after the intervention. Another limitation is that
the study was single-blinded and not double-blinded. One of the strengths of the study is that to the
best of our knowledge, this is the first randomized study including post-hospitalized elderly adults in
a resistance training program along with protein supplementation.
5. Conclusions
This study reinforces resistance training as a fundamental early intervention strategy to maintain
muscle mass and increase gains in physical function parameters in post-hospitalized elderly adults.
Thus, 12 weeks of supervised resistance training with a one-hour session over two days/week seems
enough to enhance strength and physical function variables in post-hospitalized elderly adults.
However, it does not clarify the additional benefits of a protein supplementation.
The elderly population is a very heterogenic group, so future directions should focus on conducting
studies among the different subgroups with special needs. There is a need to assess which might be
the optimum length of an interventional study including resistance exercise and supplementation to
induce gains in muscle mass and strength. Specifically, there is a growing interest in stablishing the
characteristics of the best protein supplementation protocol and differences between healthy older
adults and older adults with an acute or chronic disease and/or with one or more conditions of the
geriatric syndrome. It would also be interesting for future studies to add muscle biopsies as direct
measurements for muscle mass hypertrophy.
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